IFAM
DRNA
Institutional & Family Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16
| Closed | – | – | 976 |
|
|
2021
Q3 | $0 | Sell |
16
-35
| -69% | – | ﹤0.01% | 1001 |
|
|
2021
Q2 | $2K | Buy |
51
+14
| +38% | +$549 | ﹤0.01% | 855 |
|
|
2021
Q1 | $1K | Sell |
37
-22
| -37% | -$595 | ﹤0.01% | 919 |
|
|
2020
Q4 | $1K | Sell |
59
-2
| -3% | -$34 | ﹤0.01% | 857 |
|
|
2020
Q3 | $1K | Hold |
61
| – | – | ﹤0.01% | 818 |
|
|
2020
Q2 | $2K | Sell |
61
-18
| -23% | -$590 | ﹤0.01% | 736 |
|
|
2020
Q1 | $1K | Hold |
79
| – | – | ﹤0.01% | 794 |
|
|
2019
Q4 | $2K | Hold |
79
| – | – | ﹤0.01% | 776 |
|
|
2019
Q3 | $1K | Buy |
+79
| New | +$1K | ﹤0.01% | 818 |
|